ESTA vs SGRY
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
ESTA shows bearish fundamentals based on deterministic rules. Financial strength is weak (F-Score 3/9). Concerns include weak profitability or high valuation.
SGRY exhibits severe fundamental weakness, highlighted by a Piotroski F-Score of 2/9, indicating poor financial health and deteriorating operational efficiency. While the stock trades at a low Price-to-Sales (0.55) and Price-to-Book (1.05) ratio, these valuation metrics are offset by negative profit margins and a disastrous earnings track record, with 0 beats in the last four quarters. Stagnant revenue growth (2.40%) and aggressive insider selling by the CEO and CFO further undermine the bullish analyst consensus. The combination of a 0/100 technical trend and consistent earnings misses suggests a value trap rather than a value opportunity.
Compare Another Pair
Related Comparisons
ESTA vs SGRY: Head-to-Head Comparison
This page compares Establishment Labs Holdings Inc. (ESTA) and Surgery Partners, Inc. (SGRY) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.